Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Paul G. Kluetz"'
Autor:
Kathleen Maignan, Lola A. Fashoyin-Aje, Aracelis Z. Torres, Laura L. Fernandes, Thomas Gwise, Shrujal B. Baxi, James P. Roose, Donna R. Rivera, Yuan Li Shen, Paul G. Kluetz, Nicole J. Gormley
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 4, Pp 1-6 (2022)
Abstract This retrospective observational study evaluated racial disparities among Black and White patients with multiple myeloma (MM). We included patients from a longitudinal de-identified EHR-derived database who had ≥2 visits recorded on or aft
Externí odkaz:
https://doaj.org/article/4676e1178d1f40689b1186a68dd087aa
Autor:
Laura L. Fernandes, Jiaxi Zhou, Bindu Kanapuru, Erica Horodniceanu, Thomas Gwise, Paul G. Kluetz, Vishal Bhatnagar
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 8, Pp 1-6 (2021)
Abstract Over the past 13 years, there have been advances in characterizing the patient experience in oncology trials, primarily using patient-reported outcomes (PROs). This review aims to provide details on the PRO measures and analyses used in mult
Externí odkaz:
https://doaj.org/article/79a8fb887fae4215a318dfe915d3e787
Autor:
Clara Hwang, Monika A. Izano, Michael A. Thompson, Shirish M. Gadgeel, James L. Weese, Tom Mikkelsen, Andrew Schrag, Mahder Teka, Sheetal Walters, Frank M. Wolf, Jonathan Hirsch, Donna R. Rivera, Paul G. Kluetz, Harpreet Singh, Thomas D. Brown
Publikováno v:
Cancer Reports, Vol 4, Iss 5, Pp n/a-n/a (2021)
Abstract Background The understanding of the impact of COVID‐19 in patients with cancer is evolving, with need for rapid analysis. Aims This study aims to compare the clinical and demographic characteristics of patients with cancer (with and withou
Externí odkaz:
https://doaj.org/article/4f55d1001a2b43daa635e599e89b3b58
Autor:
Joseph S Ross, Molly Moore Jeffery, Lee Jones, Jessica D Ritchie, Cary P Gross, Jonas Paludo, Matthew Diamond, Vishal Bhatnagar, Amylou C Dueck, Kathryn J Ruddy, Gita Thanarajasingam, Abbie Brown, Elizabeth Cathcart-Rake, Louis Faust, Mallorie H Fiero, Brad Powers, Paul G Kluetz, Scott F Huntington, Brie N Noble, Sarah E Schellhorn, Michelle E Tarver
Publikováno v:
BMJ Open, Vol 14, Iss 1 (2024)
Introduction Accurate, patient-centred evaluation of physical function in patients with cancer can provide important information on the functional impacts experienced by patients both from the disease and its treatment. Increasingly, digital health t
Externí odkaz:
https://doaj.org/article/f14d933500d0462891582c165cec6a06
Autor:
Qi Liu, Raina Mathur, Yuan Xu, Aracelis Z. Torres, Rebecca A. Miksad, Chao Liu, Haixia Smithson, Yaning Wang, Hao Zhu, Brian Booth, Shiew‐Mei Huang, Jizu Zhi, Rajeshwari Sridhara, Gideon Michael Blumenthal, Erin Larkins, Pallavi S. Mishra‐Kalyani, Donna R. Rivera, Paul G. Kluetz, Elad Sharon
Publikováno v:
Clinical Pharmacology & Therapeutics. 113:1139-1149
Autor:
Qi Liu, Chenan Zhang, Yue Huang, Ruihao Huang, Shiew-Mei Huang, Erin Larkins, Liza Stapleford, Donna R. Rivera, Paul G. Kluetz, Shenggang Wang, Hao Zhu, James Weese, Elizabeth Cromartie, Mahder Teka, Sheetal Walters, Frank Wolf, Thomas D. Brown
Publikováno v:
Cancer Research Communications. 3:258-266
Pneumonitis is a potentially life-threatening complication of anticancer therapy, and future treatment decisions may be informed by characterizing patients receiving therapies in the real-world setting. In this study, the incidence of treatment-assoc
Autor:
Claire Piccinin, Ethan Basch, Vishal Bhatnagar, Melanie Calvert, Alicyn Campbell, David Cella, Charles S Cleeland, Corneel Coens, Anne-Sophie Darlington, Amylou C Dueck, Mogens Groenvold, Ralf Herold, Bellinda L King-Kallimanis, Paul G Kluetz, Dagmara Kuliś, Daniel O'Connor, Kathy Oliver, Madeline Pe, Bryce B Reeve, Jaap C Reijneveld, Xin Shelley Wang, Andrew Bottomley
Publikováno v:
Piccinin, C, Basch, E, Bhatnagar, V, Calvert, M, Campbell, A, Cella, D, Cleeland, C S, Coens, C, Darlington, A-S, Dueck, A C, Groenvold, M, Herold, R, King-Kallimanis, B L, Kluetz, P G, Kuliś, D, O'Connor, D, Oliver, K, Pe, M, Reeve, B B, Reijneveld, J C, Wang, X S & Bottomley, A 2023, ' Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials : findings from an international, multidisciplinary working group ', Lancet Oncology, vol. 24, no. 2, pp. e86-e95 . https://doi.org/10.1016/S1470-2045(22)00654-4
The use of item libraries for patient-reported outcome (PRO) measurement in oncology allows for the customisation of PRO assessment to measure key health-related quality of life concepts of relevance to the target population and intervention. However
Autor:
Asma Dilawari, Mirat Shah, Gwynn Ison, Haley Gittleman, Mallorie H. Fiero, Ankit Shah, Salaheldin S. Hamed, Junshan Qiu, Jingyu Yu, Wimolnut Manheng, Tiffany K. Ricks, Rajan Pragani, Arulvathani Arudchandran, Paresma Patel, Shadia Zaman, Arpita Roy, Shyam Kalavar, Soma Ghosh, William F. Pierce, Nam Atiqur. Rahman, Shenghui Tang, Bronwyn D. Mixter, Paul G. Kluetz, Richard Pazdur, Laleh Amiri-Kordestani
Publikováno v:
Clinical Cancer Research.
On November 14, 2022, the U.S. Food and Drug Administration (FDA) granted accelerated approval to mirvetuximab soravtansine-gynx for treatment of adult patients with folate receptor-α (FRα)-positive, platinum-resistant epithelial ovarian, fallopian
Autor:
Bellinda L King-Kallimanis, Vishal Bhatnagar, Erica G Horodniceanu, Ting-Yu Chen, Paul G Kluetz
Publikováno v:
Clinical Trials. 19:267-273
Objective Although patient-reported symptoms and side effects are increasingly measured in cancer clinical trials, an appropriate assessment frequency has not yet been established. To determine whether differences in assessment frequency affect the a
Autor:
Gita Thanarajasingam, Lori M Minasian, Vishal Bhatnagar, Franco Cavalli, R Angelo De Claro, Amylou C Dueck, Tarec C El-Galaly, Neil Everest, Jan Geissler, Christian Gisselbrecht, Nicole Gormley, John Gribben, Mary Horowitz, S Percy Ivy, Caron A Jacobson, Armand Keating, Paul G Kluetz, Yok Lam Kwong, Richard F Little, Matthew J Matasar, Maria-Victoria Mateos, Kristen McCullough, Robert S Miller, Mohamad Mohty, Philippe Moreau, Lindsay M Morton, Sumimasa Nagai, Abhilasha Nair, Loretta Nastoupil, Kaye Robertson, Surbhi Sidana, Karin E Smedby, Pieter Sonneveld, Kyriaki Tzogani, Flora E van Leeuwen, Galina Velikova, Diego Villa, John R Wingard, John F Seymour, Thomas M Habermann
Publikováno v:
Thanarajasingam, G, Minasian, L M, Bhatnagar, V, Cavalli, F, De Claro, R A, Dueck, A C, El-Galaly, T C, Everest, N, Geissler, J, Gisselbrecht, C, Gormley, N, Gribben, J, Horowitz, M, Ivy, S P, Jacobson, C A, Keating, A, Kluetz, P G, Kwong, Y L, Little, R F, Matasar, M J, Mateos, M-V, McCullough, K, Miller, R S, Mohty, M, Moreau, P, Morton, L M, Nagai, S, Nair, A, Nastoupil, L, Robertson, K, Sidana, S, Smedby, K E, Sonneveld, P, Tzogani, K, van Leeuwen, F E, Velikova, G, Villa, D, Wingard, J R, Seymour, J F & Habermann, T M 2022, ' Reaching beyond maximum grade : progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies ', The Lancet. Haematology, vol. 9, no. 5, pp. e374-e384 . https://doi.org/10.1016/S2352-3026(22)00045-X
Lancet Haematol
Lancet Haematol
Remarkable improvements in outcomes for many haematological malignancies have been driven primarily by a proliferation of novel therapeutics over the past two decades. Targeted agents, immune and cellular therapies, and combination regimens have adve